Clinical research is regulated to make sure it is conducted to a high professional and scientific standard. In Australia, several committees examine and approve a clinical research study before it begins.
Learn more about:
The following committees confirm that a study is considered scientifically worthwhile and fair to the participants (ethical). They also check that the study meets any regulatory requirements set out in State and Commonwealth legislation.
- Research or scientific review committee – decides whether the study has social and scientific value, and if the way it is going to be conducted will produce valid scientific results. May be a subcommittee of a human research ethics committee.
- Human research ethics committee (HREC) – confirms that the interests of participants are protected and that researchers will run the study in a fair, honest and neutral (impartial) way. It ensures researchers won’t force people into participating, and that the risks of the research generally don’t outweigh the benefits.
- Research governance review – checks every site where the research will take place. This review is done by a research governance officer, who makes sure there are enough resources to carry out the proposed research and that the staff members involved are qualified. The governance officer authorises the research to begin at each site.
The study may also be monitored by outside agencies such as pharmaceutical companies, research institutions and auditors. These bodies ensure that the research is carried out properly.
Clinical research standards
All health professionals must follow a set of international standards for designing, conducting, recording and reporting clinical research called Good Clinical Practice (GCP). These standards ensure that people taking part are safe, their privacy is protected, information is collected to the highest standard, and results are reliable. GCP is the same anywhere in the world where clinical research is conducted.
Once a study has been approved by a research review committee, the HREC assesses the impact of the proposed research on participants, researchers and the general community. The impact is then weighed up against the benefits of conducting the research. The committee makes sure that the study will be carried out in a way that protects participants.
The HREC reviews a number of aspects of the study, including:
- the qualifications of the researchers conducting the study
- the way participants are recruited
- the quality of the participant information
- how risks to participants will be minimised
- how participants’ personal information will be used and stored
- how the study might impact on the participants’ quality of life.
Committee members are always independent of the researchers. They come from a variety of backgrounds, including medical, scientific, legal and religious professions, and the general community. To reflect different points of view and provide balance, the HREC will consist of at least eight core members with a range of experiences.
A research study cannot begin until it has received approval from the HREC and the governance office. For more information on how studies are conducted fairly, see Types of clinical trials.
Sometimes changes need to be made to the research:
- Before approval – The HREC may ask the research team to make changes to the proposed research before it can go ahead.
- After approval – Any changes that researchers want to make during the study must go through ethics approval again before the change can take place. For example, the researchers may want to expand the size of the study, or some safety information may have become available about the intervention. This is called an amendment.
If there are any changes to the participant information, participants already taking part in the study may need to sign a form to show that they have been told about the changes (amendment) and still agree be involved.
|Therapeutic Goods Administration
The Therapeutic Goods Administration (TGA) is an Australian Government department that regulates all medicines sold in Australia. Any experimental drug used in a clinical trial must be registered with the TGA. For more on this, visit tga.gov.au.
Download a PDF booklet on this topic.
A/Prof Andrew Redfern, Consultant Medical Oncologist, Fiona Stanley Hospital, Clinical Academic Oncologist, The University of Western Australia, and Lead Clinician, State Breast Cancer Collaborative, WA; Christie Allan, Program Coordinator – Clinical Trials, Cancer Council Victoria; Bronwyn Chalmers, Clinical Trial Coordinator, Westmead Breast Cancer Institute, NSW; Sarah Coulson, Coordinator, Oncology Clinical Trials, Projects and Research, Tasmanian Health Service, TAS; Kate Cox, 13 11 20 Consultant, Cancer Council SA; Annette Cubitt, Clinical Trials Manager, Department of Medical Oncology, Cancer Care Services, Royal Brisbane and Women’s Hospital, QLD; Pete Currie, Consumer; Amy Ives, Clinical Trials Coordinator, Department of Medical Oncology, Cancer Care Services, Royal Brisbane and Women’s Hospital, QLD; Sabina Jelinek, Clinical Research Nurse, Murdoch Oncology Clinical Trials Unit, WA; Dr Visalini Nair-Shalliker, Research Fellow – Prostate, Cancer Council NSW; Karlie Neilson, Project Officer – Cancer Research Division, Cancer Council NSW; Prof Mark Rosenthal, Medical Oncologist, and Director, Parkville Cancer Clinical Trials Unit, VIC; Joan Torony, CEO, TROG Cancer Research, NSW; Rebecca Weselman, Senior Clinical Trials Coordinator, Oncology Clinical Trials, St John of God Murdoch Hospital, WA; John Williams, Research Governance Officer, Cancer Council NSW.
View the Cancer Council NSW editorial policy.
Coping with cancer?
Speak to a health professional or to someone who has been there, or find a support group or forum
Need legal and financial assistance?
Pro bono services, financial and legal assistance, and no interest loans
Looking for transport, accommodation or home help?
Practical advice and support during and after treatment
Learn about common cancer treatments, such as surgery, chemotherapy and radiation therapy
Dealing with the diagnosis
Common reactions to a cancer diagnosis and how to find hope
View our publications
Guides and fact sheets for people with cancer, their families and friends